Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boneschi

Showing results (271-280 of 310) with videos related to

Pageof 31
Sort By:
Plos One|June 21, 2013
Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patientsMaurizio A Leone, Nadia Barizzone, Federica Esposito, et al.
Annals of Neurology|April 28, 2015
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activityFederica Esposito, Melissa Sorosina, Linda Ottoboni, et al.
Plos One|February 23, 2010
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female populationMichele Mishto, Elena Bellavista, Claudia Ligorio, et al.
Acta Neurologica Scandinavica|July 24, 2018
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment responseMarzia A L Romeo, Vittorio Martinelli, Gloria Dalla Costa, et al.
Plos One|September 3, 2020
Evaluation of molecular inversion probe versus TruSeq® custom methods for targeted next-generation sequencingRowida Almomani, Margherita Marchi, Maurice Sopacua, et al.
European Journal of Neurology|April 23, 2022
COVID-19 vaccination hesitancy among people with chronic neurological disorders: A position paperMartin Rakusa, Serefnur Öztürk, Elena Moro, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|August 6, 2021
Genomic and functional evaluation of TNFSF14 in multiple sclerosis susceptibilityMiriam Zuccalà, Nadia Barizzone, Elena Boggio, et al.
Journal of Neuroimmunology|September 6, 2011
IL28B polymorphisms are not associated with the response to interferon-β in multiple sclerosisS Malhotra, C Morcillo-Suárez, D Brassat, et al.
The Pharmacogenomics Journal|March 23, 2016
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association studyS Mahurkar, M Moldovan, V Suppiah, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2026
Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric studyAndrea Corona, Ferdinando Clarelli, Kimmo Pääkkönen, et al.
Pageof 31

Showing results (271-280 of 310) with videos related to

Sort By:
Pageof 31
Plos One|June 21, 2013
Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patientsMaurizio A Leone, Nadia Barizzone, Federica Esposito, et al.
Annals of Neurology|April 28, 2015
A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activityFederica Esposito, Melissa Sorosina, Linda Ottoboni, et al.
Plos One|February 23, 2010
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female populationMichele Mishto, Elena Bellavista, Claudia Ligorio, et al.
Acta Neurologica Scandinavica|July 24, 2018
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment responseMarzia A L Romeo, Vittorio Martinelli, Gloria Dalla Costa, et al.
Plos One|September 3, 2020
Evaluation of molecular inversion probe versus TruSeq® custom methods for targeted next-generation sequencingRowida Almomani, Margherita Marchi, Maurice Sopacua, et al.
European Journal of Neurology|April 23, 2022
COVID-19 vaccination hesitancy among people with chronic neurological disorders: A position paperMartin Rakusa, Serefnur Öztürk, Elena Moro, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|August 6, 2021
Genomic and functional evaluation of TNFSF14 in multiple sclerosis susceptibilityMiriam Zuccalà, Nadia Barizzone, Elena Boggio, et al.
Journal of Neuroimmunology|September 6, 2011
IL28B polymorphisms are not associated with the response to interferon-β in multiple sclerosisS Malhotra, C Morcillo-Suárez, D Brassat, et al.
The Pharmacogenomics Journal|March 23, 2016
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association studyS Mahurkar, M Moldovan, V Suppiah, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2026
Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric studyAndrea Corona, Ferdinando Clarelli, Kimmo Pääkkönen, et al.
Pageof 31